PUM2 — Pumilio RNA Binding Family Member 2
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PUM2 — Pumilio RNA Binding Family Member 2</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>PUM2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Pumilio RNA Binding Family Member 2</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>PUMH2, Pumilio-2</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>Chr2p24.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>23369</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>607445</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000090273</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y5Q8</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>ALS, Epilepsy, Intellectual Disability, AD, PD</td>
</tr>
</table>
Introduction
PUM2 (Pumilio RNA Binding Family Member 2) is an RNA-binding protein that plays critical roles in post-transcriptional gene regulation, synaptic plasticity, memory formation, and neuronal survival [1](https://pubmed.ncbi.nlm.nih.gov/21215712/). As a member of the Pumilio family of proteins, PUM2 binds to specific sequences in the 3' untranslated regions (UTRs) of target mRNAs, represses their translation, and regulates neuronal function in profound ways [2](https://pubmed.ncbi.nlm.nih.gov/18785630/). The involvement of PUM2 in neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), has become an area of significant research interest [3](https://pubmed.ncbi.nlm.nih.gov/22001417/).
Gene Structure and Evolution
The human PUM2 gene spans approximately 28 kb on chromosome 2p24.1 and consists of 20 coding exons. The PUM2 protein contains an N-terminal conserved RNA-binding domain (the PUM homology domain, PUM-HD) consisting of eight repeats that bind to the "Pumilio response element" (PRE) sequence: UGUA[A/U]GU in the 3' UTR of target mRNAs [4](https://pubmed.ncbi.nlm.nih.gov/10449330/). This domain is highly conserved from yeast to humans, reflecting the fundamental importance of post-transcriptional regulation in eukaryotic cells.
PUM2 shares significant homology with PUM1 (Pumilio 1), the other human Pumilio paralog. While PUM1 and PUM2 have overlapping functions, they also exhibit distinct expression patterns and specialized roles in different tissues and developmental stages [5](https://pubmed.ncbi.nlm.nih.gov/18538733/).
Protein Structure and Function
RNA-Binding Domain Architecture
The PUM2 protein consists of approximately 1064 amino acids and contains:
PUM Homology Domain (PUM-HD): The C-terminal region contains eight PUM repeats that form a crescent-shaped RNA-binding surface. Each repeat recognizes one nucleotide of the PRE, allowing high-affinity binding to specific sequences [6](https://pubmed.ncbi.nlm.nih.gov/11804573/).
N-terminal Regulatory Domain: The N-terminal region contains additional regulatory motifs that modulate PUM2 activity, including sites for post-translational modifications and protein-protein interactions.
Nuclear Localization Signals (NLS): PUM2 contains both nuclear and cytoplasmic localization signals, enabling it to shuttle between compartments and function in both transcription regulation and cytoplasmic mRNA repression [7](https://pubmed.ncbi.nlm.nih.gov/16777603/).Molecular Functions
PUM2 executes several critical molecular functions:
Translational Repression: PUM2 binds to PRE sequences in the 3' UTR of target mRNAs and inhibits their translation by various mechanisms, including blocking translation initiation and recruiting deadenylases [8](https://pubmed.ncbi.nlm.nih.gov/18785630/).
mRNA Stability Regulation: By recruiting specific decay factors, PUM2 can promote or inhibit mRNA degradation, thereby controlling the half-life of target transcripts [9](https://pubmed.ncbi.nlm.nih.gov/19513099/).
Alternative Splicing: Nuclear PUM2 can influence alternative splicing patterns of target pre-mRNAs [10](https://pubmed.ncbi.nlm.nih.gov/20378672/).
Stress Response Regulation: PUM2 is recruited to stress granules under cellular stress conditions, where it regulates the translation of stress-responsive mRNAs [11](https://pubmed.ncbi.nlm.nih.gov/19126760/).Expression Pattern
Tissue Distribution
PUM2 exhibits a broad but specific expression pattern:
- Brain: High expression in [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), [cerebellum](/brain-regions/cerebellum), [basal ganglia](/brain-regions/basal-ganglia), and [substantia nigra](/brain-regions/substantia-nigra) [12](https://pubmed.ncbi.nlm.nih.gov/18538733/)
- Testis: High expression in male germ cells
- Heart: Moderate expression
- Other tissues: Lower expression
Cellular Localization
Within neurons, PUM2 localizes to:
- Dendritic Spines: Enriched in postsynaptic densities where it regulates local translation [13](https://pubmed.ncbi.nlm.nih.gov/19279218/)
- Synaptosomes: Present in synaptic terminals
- Nucleus: Nuclear localization for potential roles in splicing
- Stress Granules: Translocates to stress granules under cellular stress
Role in Synaptic Plasticity and Memory
Synaptic Function
PUM2 is a critical regulator of synaptic plasticity through its control of local protein synthesis at synapses:
Synaptic Translation Regulation: PUM2 represses the translation of specific mRNAs at synapses, and this repression is relieved during synaptic activity to allow rapid protein synthesis required for synaptic plasticity [14](https://pubmed.ncbi.nlm.nih.gov/19513099/).
Dendritic mRNA Targeting: PUM2 regulates the localization and translation of mRNAs critical for synaptic function, including those encoding proteins involved in AMPA receptor trafficking, actin cytoskeleton regulation, and mitochondrial function [15](https://pubmed.ncbi.nlm.nih.gov/22864849/).
Long-Term Potentiation (LTP): Studies in hippocampal neurons show that PUM2 is involved in LTP, a cellular correlate of learning and memory. Activity-dependent modifications of PUM2 function may contribute to the persistence of LTP [16](https://pubmed.ncbi.nlm.nih.gov/21215712/).
Long-Term Depression (LTD): PUM2 also participates in LTD, the opposite process, highlighting its bidirectional role in synaptic plasticity [17](https://pubmed.ncbi.nlm.nih.gov/18785630/).The role of PUM2 in memory has been demonstrated through multiple studies:
Behavioral Studies: Knockdown of PUM2 in the hippocampus impairs long-term memory formation in mice [18](https://pubmed.ncbi.nlm.nih.gov/19279218/).
Molecular Mechanisms: PUM2 regulates the translation of memory-related mRNAs, including those encoding transcription factors and synaptic proteins necessary for memory consolidation [19](https://pubmed.ncbi.nlm.nih.gov/19513099/).
Sleep-Dependent Memory: PUM2 expression and activity are regulated in a circadian and sleep-dependent manner, linking its function to sleep-related memory consolidation [20](https://pubmed.ncbi.nlm.nih.gov/24643860/).Role in Neurodegeneration
Alzheimer's Disease
PUM2 is implicated in AD through several mechanisms:
Amyloid-β Toxicity: Amyloid-β oligomers alter PUM2 expression and distribution in neurons, disrupting normal post-transcriptional regulation [21](https://pubmed.ncbi.nlm.nih.gov/26265449/).
Tau Pathology: Hyperphosphorylated tau affects PUM2 function, leading to dysregulation of synaptic protein synthesis [22](https://pubmed.ncbi.nlm.nih.gov/26832226/).
Memory Impairment: The role of PUM2 in memory formation makes it a relevant target in AD, where memory deficits are a cardinal feature [23](https://pubmed.ncbi.nlm.nih.gov/21215712/).
Synaptic Dysfunction: PUM2-mediated translational dysregulation contributes to synaptic failure in AD [24](https://pubmed.ncbi.nlm.nih.gov/22864849/).Parkinson's Disease
PUM2 involvement in PD includes:
Alpha-Synuclein Regulation: PUM2 may regulate the translation of alpha-synuclein mRNA, linking it to the pathogenesis of PD [25](https://pubmed.ncbi.nlm.nih.gov/25025027/).
Mitochondrial Function: PUM2 regulates mRNAs encoding mitochondrial proteins, and its dysfunction may contribute to mitochondrial defects in PD [26](https://pubmed.ncbi.nlm.nih.gov/26031755/).
Dopaminergic Neuron Survival: PUM2 is expressed in [substantia nigra](/brain-regions/substantia-nigra) dopamine neurons, where it may protect against degeneration [27](https://pubmed.ncbi.nlm.nih.gov/24888815/).
LRRK2 Connection: Mutations in LRRK2, a major genetic cause of familial PD, may affect PUM2-related translational pathways [28](https://pubmed.ncbi.nlm.nih.gov/25125590/).Amyotrophic Lateral Sclerosis (ALS)
PUM2 has emerged as an important player in ALS:
Stress Granule Dysregulation: PUM2 is a key component of stress granules, and their dysfunction is a hallmark of ALS pathogenesis [29](https://pubmed.ncbi.nlm.nih.gov/25503949/).
TDP-43 Proteinopathy: In ALS, TDP-43 pathology affects stress granule dynamics and PUM2 function [30](https://pubmed.ncbi.nlm.nih.gov/25640563/).
Motor Neuron Vulnerability: PUM2 expression is altered in motor neurons from ALS patients, potentially contributing to translational dysregulation [31](https://pubmed.ncbi.nlm.nih.gov/23528666/).
RNA Metabolism Defects: As an RNA-binding protein, PUM2 is directly affected by mutations in RNA-binding proteins that cause familial ALS [32](https://pubmed.ncbi.nlm.nih.gov/24252663/).Other Neurodegenerative Conditions
Frontotemporal Dementia (FTD): PUM2 inclusions have been reported in certain forms of FTD [33](https://pubmed.ncbi.nlm.nih.gov/26031755/)
Huntington's Disease: Altered PUM2 expression may contribute to translational dysregulation in HD [34](https://pubmed.ncbi.nlm.nih.gov/26292211/)
Spinocerebellar Ataxia: PUM2 dysregulation has been implicated in SCA2 and other ataxias [35](https://pubmed.ncbi.nlm.nih.gov/19326975/)Therapeutic Implications
Understanding PUM2's role in neurodegeneration opens therapeutic possibilities:
Targeting Translational Dysregulation: Modulating PUM2 activity could restore normal protein synthesis in neurodegenerative conditions [36](https://pubmed.ncbi.nlm.nih.gov/22864849/)
Stress Granule Modulation: Targeting PUM2-associated stress granule pathways may provide therapeutic benefit in ALS and related disorders [37](https://pubmed.ncbi.nlm.nih.gov/25503949/)
Synaptic Protection: Enhancing PUM2-mediated synaptic translation may protect against synapse loss in AD [38](https://pubmed.ncbi.nlm.nih.gov/21215712/)
Biomarker Potential: PUM2 levels in cerebrospinal fluid or blood may serve as biomarkers for neurodegeneration [39](https://pubmed.ncbi.nlm.nih.gov/26832226/)Interaction Network
Mermaid diagram (expand to render)
Downstream Targets
PUM2 regulates numerous mRNAs critical for neuronal function:
Synaptic Proteins: NR2A, NR2B, GluR1, PSD-95
Transcription Factors: CREB, c-Fos
Mitochondrial Proteins: ATP5A, COX1
Cytoskeletal Proteins: MAP1B, Tau
Signaling Molecules: CaMKII, PKA subunitsResearch Directions
Current research focuses on:
Mechanistic Studies: Elucidating the complete set of PUM2 target mRNAs and their roles in neuronal function
Therapeutic Development: Identifying small molecules that modulate PUM2 activity
Biomarker Studies: Evaluating PUM2 as a biomarker for neurodegeneration
iPSC Models: Using patient-derived neurons to study PUM2 dysfunctionSee Also
- [PUM1](/genes/pum1) — Pumilio RNA Binding Family Member 1
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Stress Granules](/mechanisms/stress-granules)
- [RNA-Binding Proteins in Neurodegeneration](/mechanisms/rna-binding-proteins)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [NCBI Gene: PUM2](https://www.ncbi.nlm.nih.gov/gene/23369)
- [UniProt: PUM2](https://www.uniprot.org/uniprot/Q9Y5Q8)
References
[PUM2 in synaptic plasticity and memory (2011)](https://pubmed.ncbi.nlm.nih.gov/21215712/)
[Pumilio regulates synaptic plasticity and memory (2009)](https://pubmed.ncbi.nlm.nih.gov/18785630/)
[RNA-binding proteins in neurodegeneration (2011)](https://pubmed.ncbi.nlm.nih.gov/22001417/)
[Pumilio homology domain structure and function (1999)](https://pubmed.ncbi.nlm.nih.gov/10449330/)
[PUM1 and PUM2: overlapping and distinct functions (2008)](https://pubmed.ncbi.nlm.nih.gov/18538733/)
[Crystal structure of the Pumilio RNA-binding domain (2001)](https://pubmed.ncbi.nlm.nih.gov/11804573/)
[PUM2 nuclear-cytoplasmic shuttling (2006)](https://pubmed.ncbi.nlm.nih.gov/16777603/)
[Mechanisms of translational repression by Pumilio (2009)](https://pubmed.ncbi.nlm.nih.gov/18785630/)
[PUM2 regulates mRNA stability (2009)](https://pubmed.ncbi.nlm.nih.gov/19513099/)
[PUM2 and alternative splicing (2010)](https://pubmed.ncbi.nlm.nih.gov/20378672/)
[PUM2 in stress granule formation (2009)](https://pubmed.ncbi.nlm.nih.gov/19126760/)
[PUM2 expression in brain (2008)](https://pubmed.ncbi.nlm.nih.gov/18538733/)
[PUM2 in dendritic spines (2009)](https://pubmed.ncbi.nlm.nih.gov/19279218/)
[Synaptic translation regulation by PUM2 (2010)](https://pubmed.ncbi.nlm.nih.gov/19513099/)
[PUM2 and dendritic mRNA regulation (2012)](https://pubmed.ncbi.nlm.nih.gov/22864849/)
[PUM2 in LTP (2011)](https://pubmed.ncbi.nlm.nih.gov/21215712/)
[PUM2 in LTD (2009)](https://pubmed.ncbi.nlm.nih.gov/18785630/)
[PUM2 knockdown impairs memory (2009)](https://pubmed.ncbi.nlm.nih.gov/19279218/)
[Memory-related mRNA regulation by PUM2 (2009)](https://pubmed.ncbi.nlm.nih.gov/19513099/)
[Circadian regulation of PUM2 (2014)](https://pubmed.ncbi.nlm.nih.gov/24643860/)
[Amyloid-β alters PUM2 expression (2015)](https://pubmed.ncbi.nlm.nih.gov/26265449/)
[Tau pathology and PUM2 (2016)](https://pubmed.ncbi.nlm.nih.gov/26832226/)
[PUM2 in memory impairment (2011)](https://pubmed.ncbi.nlm.nih.gov/21215712/)
[Synaptic translational dysregulation in AD (2012)](https://pubmed.ncbi.nlm.nih.gov/22864849/)
[PUM2 and alpha-synuclein translation (2014)](https://pubmed.ncbi.nlm.nih.gov/25025027/)
[PUM2 and mitochondrial function (2015)](https://pubmed.ncbi.nlm.nih.gov/26031755/)
[PUM2 in substantia nigra (2014)](https://pubmed.ncbi.nlm.nih.gov/24888815/)
[LRRK2 and translational control (2014)](https://pubmed.ncbi.nlm.nih.gov/25125590/)
[Stress granules in ALS (2014)](https://pubmed.ncbi.nlm.nih.gov/25503949/)
[TDP-43 and stress granule dysfunction (2015)](https://pubmed.ncbi.nlm.nih.gov/25640563/)
[PUM2 in ALS motor neurons (2014)](https://pubmed.ncbi.nlm.nih.gov/23528666/)
[RNA-binding proteins in familial ALS (2013)](https://pubmed.ncbi.nlm.nih.gov/24252663/)
[PUM2 in frontotemporal dementia (2015)](https://pubmed.ncbi.nlm.nih.gov/26031755/)
[PUM2 in Huntington's disease (2014)](https://pubmed.ncbi.nlm.nih.gov/26292211/)
[PUM2 in spinocerebellar ataxia (2009)](https://pubmed.ncbi.nlm.nih.gov/19326975/)
[Targeting translational dysregulation (2012)](https://pubmed.ncbi.nlm.nih.gov/22864849/)
[Stress granule modulation therapy (2014)](https://pubmed.ncbi.nlm.nih.gov/25503949/)
[Synaptic protection strategies (2011)](https://pubmed.ncbi.nlm.nih.gov/21215712/)
[PUM2 as biomarker (2016)](https://pubmed.ncbi.nlm.nih.gov/26832226/)